Mesenchymal stem cells genetically modified by lentivirus-mediated interleukin-12 inhibit malignant ascites in mice

The objective of the present study was to investigate the effects of mesenchymal stem cells (MSCs) genetically modified by lentivirus-mediated mouse interleukin-12 (Lenti-mIL-12) in treating malignant ascites in mice. The in vitro chemotactic effect of Lenti-mIL-12-MSC culture supernatant on dendrit...

Descripción completa

Detalles Bibliográficos
Autores principales: HAN, JIMING, ZHAO, JUMEI, XU, JIANRONG, WEN, YANJUN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151654/
https://www.ncbi.nlm.nih.gov/pubmed/25187849
http://dx.doi.org/10.3892/etm.2014.1918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151654/
https://www.ncbi.nlm.nih.gov/pubmed/25187849
http://dx.doi.org/10.3892/etm.2014.1918

Ejemplares similares